Revumenib Approved for KMT2A Translocation Leukemia ...Middle East

Medscape - News
The oral small molecule is the first drug approved for a major driver of acute leukemia in infants. Medscape Medical News

Hence then, the article about revumenib approved for kmt2a translocation leukemia was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Revumenib Approved for KMT2A Translocation Leukemia )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News